Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Aspira Women's Health Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q3 2023
- Shares held
- 715.3K
- +57.5K (+8.7%) vs. Q3 2023
- Total value
- $2.92M
- −$608.5K (−17.3%) vs. Q3 2023
- New holders
- 5
- 10 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 196,007 | $799.7K | 0.00% | +13,162+7.2% | Added |
| National Asset Management, Inc. | 179,371 | $731.8K | 0.02% | +53,997+43.1% | Added |
| BlackRock Inc. | 62,766 | $256.1K | 0.00% | −403−0.6% | Reduced |
| Geode Capital Management, LLC | 57,329 | $234.0K | 0.00% | +5,571+10.8% | Added |
| Quantum Private Wealth, LLC | 50,156 | $204.6K | 0.09% | +21,788+76.8% | Added |
| Northern Trust Corp | 36,049 | $147.1K | 0.00% | +25,047+227.7% | Added |
| Bank of America Corp | 29,183 | $119.1K | 0.00% | +11,308+63.3% | Added |
| Northeast Financial Consultants Inc | 23,436 | $95.6K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 18,249 | $74.5K | 0.00% | +2,200+13.7% | Added |
| Squarepoint Ops LLC | 15,365 | $62.7K | 0.00% | +15,365 | New |
| M&T Bank Corp | 14,999 | $61.2K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 11,262 | $45.0K | 0.00% | +11,262 | New |
| Royal Bank of Canada | 9,317 | $38.0K | 0.00% | +9,317 | New |
| Morgan Stanley | 2,274 | $9.28K | 0.00% | +167+7.9% | Added |
| Advisor Group Holdings, Inc. | 2,239 | $9.13K | 0.00% | −2,655−54.3% | Reduced |
| JPMorgan Chase & Co | 2,074 | $8.46K | 0.00% | +4+0.2% | Added |
| Tower Research Capital LLC (TRC) | 1,864 | $7.61K | 0.00% | +1,444+343.8% | Added |
| Castleview Partners, LLC | 1,316 | $5.37K | 0.00% | 00.0% | Unchanged |
| Operose Advisors LLC | 1,000 | $4.08K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 493 | $2.01K | 0.00% | +493 | New |
| UBS Group AG | 381 | $1.55K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 119 | $486 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 49 | $200 | 0.00% | −106−68.4% | Reduced |
| FMR LLC | 26 | $106 | 0.00% | +26 | New |
| Perkins Capital Management Inc | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −36,809−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,156−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,504−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |